Thiruvananthapuram: After inoculation of health workers in Kerala for nearly a month, the focus of the coronavirus vaccination drive shifted on Thursday to frontline workers from the revenue, police, fire…
AstraZeneca
-
-
Brussels: The European Commission has granted conditional marketing authorization for the Covid-19 vaccine developed by British company AstraZeneca and Oxford University, although the bloc seems unlikely to get the amount…
-
New Delhi: With the UK giving the green light to the Covid-19 vaccine developed by Oxford University and drug maker AstraZeneca, India is also expected to follow suit soon as…
-
Uncategorized
Lung Cancer Detection : Mumbai based Qure.ai and AstraZeneca partner to bring AI solutions
New Delhi : British-Swedish pharmaceutical firm AstraZeneca on Monday announced a partnership with Mumbai-based Qure.ai, a healthcare startup to integrate innovative artificial intelligence (AI) solutions for the early detection of…
-
Pune: Serum Institute of India has sought government consent for emergency approval of the COVID-19 vaccine that it is emerging with the University of Oxford and British drugmaker AstraZeneca. A…
-
New Delhi : Brazilian health authority Envisa said on Wednesday that a volunteer has died in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and the University of…
-
New Delhi : In the midst of the devastation of the Covid-19 pandemic, the practice of vaccination of the coronavirus continues. Meanwhile, the shocking news is that Johnson & Johnson…
-
Uncategorized
‘Side Effects In The Trial Of AstraZeneca Were Not Due To COVID-19 Shot’, Says Oxford University
New Delhi : Side effects in the trial of AstraZeneca were not caused by the COVID-19 shot. The news agency Reuters quoted Oxford University in its report. The trial of…
-
Uncategorized
Serum Institute Will Be Able To Resume Trial Of Oxford Vaccine, Gets Approval From DCGI
Pune : The Drugs Controller General of India (DGCI) doctor VG Somani on Tuesday cleared the Serum Institute of India (SII) to resume the trial of Oxford-AstraZeneca COVID-19 Vaccine. DCGI…
-
Uncategorized
DCGI’s Notice To Serum Institute For Not Pausing Vaccine Trial Even After The ‘News Of Serious Adverse Effects’
Pune : Central drug regulator Drug Controller General of India after the closure of clinical trials of the Oxford COVID-19 vaccine in other countries by the pharma company Astra Zen…